LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Home・Listă Acțiuni・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Închisă

Sector Sănătate

598.53 1.24

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

591.37

Maxim

607.39

Indicatori cheie
By Trading Economics
Venit	220M 1.5B
Vânzări	200M 11B
P/E Medie Sector	37.62 112.16
EPS	5.37
Marjă de profit	14.687
Angajați	122,000
EBITDA	-1M 2.8B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+12.06 upside

Dividende
By Dow Jones
Următoarele câștiguri	23 oct. 2024
Următoarea dată ex-dividende	12 dec. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	-9.3B 225B
Deschiderea anterioară	597.29
Închiderea anterioară	598.53

Sentimentul știrilor

By Acuity

26%

74%

57 / 366 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

589.87 / 599.35 Suport & Rezistență

Thermo Fisher Scientific Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 apr. 2024, 10:37 UTC

Câștiguri

Thermo Fisher Scientific 1Q Revenue Tops Estimates, Raises 2024 Outlook

31 ian. 2024, 11:33 UTC

Câștiguri

Thermo Fisher Scientific 4Q Profit Rises While Sales Slip

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher Had Seen 2024 Adjusted EPS $21.14-$22.02 >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 2Q EPS $4.04 >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Adj EPS $5.37 >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher Sees FY Rev $42.4B-$43.3B >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Net $1.55B >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Core Organic Revenue 0% >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 2Q Rev $10.54B >TMO

24 iul. 2024, 10:00 UTC

Câștiguri

Thermo Fisher Sees FY Adj EPS $21.29-Adj EPS $22.07 >TMO

10 iul. 2024, 12:03 UTC

Achiziții, Fuziuni, Preluări

Thermo Fisher: Subsequent Offering Period Scheduled to Expire at 5 P.M. EDT on July 16 >TMO

10 iul. 2024, 12:00 UTC

Achiziții, Fuziuni, Preluări

Thermo Fisher Scientific Completes Acquisition Of Olink, Announces Commencement Of Subsequent Offering Period >TMO OLK

8 iul. 2024, 11:38 UTC

Achiziții, Fuziuni, Preluări

Olink Announces Receipt of UK CMA Clearance for Proposed Acquisition by Thermo Fisher

8 iul. 2024, 10:39 UTC

Achiziții, Fuziuni, Preluări

CMA Launched Probe into Thermo Fisher/Olink in May

24 apr. 2024, 10:01 UTC

Câștiguri

Thermo Fisher Had Seen 2024 Rev $42.1B-$43.3B, Adjusted EPS $20.95-$22.00 >TMO

24 apr. 2024, 10:01 UTC

Câștiguri

Thermo Fisher Raises 2024 View To Adj EPS $21.14-Adj EPS $22.02 >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher Raises 2024 View To Rev $42.3B-$43.3B >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 1Q Rev $10.34B >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 1Q Net $1.33B >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 1Q EPS $3.46 >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 1Q Adj EPS $5.11 >TMO

24 apr. 2024, 10:00 UTC

Câștiguri

Thermo Fisher 1Q Core Organic Revenue Down 3% >TMO

23 mar. 2024, 13:00 UTC

Top știri

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

31 ian. 2024, 11:01 UTC

Câștiguri

Thermo Fisher Sees 2024 Rev $42.1B-$43.3B >TMO

31 ian. 2024, 11:01 UTC

Câștiguri

Thermo Fisher Sees 2024 Adj EPS $20.95-Adj EPS $22.00 >TMO

31 ian. 2024, 11:00 UTC

Câștiguri

Thermo Fisher 4Q Core Organic Revenue Down 4% >TMO

31 ian. 2024, 11:00 UTC

Câștiguri

Thermo Fisher 4Q Net $1.63B >TMO

31 ian. 2024, 11:00 UTC

Câștiguri

Thermo Fisher 4Q EPS $4.20 >TMO

31 ian. 2024, 11:00 UTC

Câștiguri

Thermo Fisher 4Q Adj EPS $5.67 >TMO

31 ian. 2024, 11:00 UTC

Câștiguri

Thermo Fisher 4Q Rev $10.89B >TMO

Comparație

Modificare preț

Thermo Fisher Scientific Inc Așteptări

Obiectiv de preț

By TipRanks

12.06% sus

Prognoză pe 12 luni

Medie 662.89 USD 12.06%

Maxim 767 USD

Minim 620 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruThermo Fisher Scientific Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

19 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 19 analiști care au acordat evaluări ale acțiunilor Thermo Fisher Scientific Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

589.87 / 599.35Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

57 / 366 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.